JunD Regulates Pancreatic β-Cells Function by Altering Lipid Accumulation.

Area of Science:

• Endocrinology
• Molecular Biology
• Metabolic Diseases

Background:

• Pancreatic beta-cell dysfunction, driven by lipotoxicity, is a key factor in type 2 diabetes mellitus development.
• JunD, a member of Activator Protein 1, influences apoptosis, oxidative stress, and lipid metabolism in various cell types.

Purpose of the Study:

• To investigate the role of JunD in pancreatic beta-cells under lipotoxic conditions.
• To determine JunD's impact on lipid metabolism and insulin secretion in beta-cells.

Main Methods:

• Utilized INS-1 cells to model lipotoxicity using palmitic acid (PA).
• Employed JunD small-interfering RNA (siRNA) to assess JunD's regulatory effects.
• Measured intracellular lipid accumulation, insulin secretion, and gene expression related to lipid metabolism and beta-cell function.

Main Results:

• Palmitic acid induced JunD overexpression, impaired glucose-stimulated insulin secretion, and increased intracellular lipid accumulation in beta-cells.
• JunD overexpression upregulated genes involved in lipid metabolism (Scd1, Fabp4, Fas, Cd36, Lpl, Plin5) and downregulated key beta-cell function genes (Pdx1, Nkx6.1, Glut2, Irs-2).
• JunD gene silencing reversed the lipotoxic effects of PA on beta-cells, including lipid accumulation and functional impairments.

Conclusions:

• JunD plays a critical role in regulating pancreatic beta-cell function and lipid accumulation under lipotoxic conditions.
• JunD may represent a novel therapeutic target for managing type 2 diabetes mellitus by modulating beta-cell lipotoxicity.